Most recently, results of oral indibulin in combination with oral capecitabine (Xeloda(R)) were presented at last year's American Society of Clinical ...
... was approved in combination with capecitabine (Xeloda, Hoffmann-LaRoche, Inc) for the treatment of advanced or metastatic HER2-positive breast cancer in ...
29, 2010 9:27AM EST A woman dying of breast cancer who was forced to battle the medicare bureaucracy in her final months has succeeded in obtaining a drug ...
... is approved for use in combination with Xeloda® (capecitabine) for the treatment of patients with HER2-positive, advanced breast cancer who have ...
Sales of Xeloda (capecitabine), for colorectal, stomach and breast cancer, increased 7% to 1.3 billion francs, driven primarily by strong gains in the ...
These drugs are used to treat blood, intestine and breast malignancies. Methotrexate not only has anti-cancer properties but also lowers the immune system's ...
In a small randomized clinical trial, breast cancer patients experiencing joint pain and stiffness from aromatase inhibitor (AI) treatment reported an ...
Array announced positive interim results of this trial at the 2009 San Antonio Breast Cancer Symposium. These results showed that ARRY-380 at doses greater ...
"The positive clinical data reported with T-DM1 at the San Antonio Breast Cancer Symposium in December and with our IMGN901 compound at AACR-NCI-EORTC ...
Email this story
